Catalog Number 306572 |
Device Problem
Delivered as Unsterile Product (1421)
|
Patient Problem
Sepsis (2067)
|
Event Date 09/21/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Date of event: unknown.The date received by manufacturer has been used for this field.A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.(b)(4).
|
|
Event Description
|
It was reported that the patient developed sepsis after using syringe 10ml saline xs.The following information was provided by the initial reporter: we have a customer complaint about the following product: ref 306572 / lot 0154145 the patient has developed sepsis after connecting the nutritional solution.We ask that the batch of bd posiflush be examined to determine if it could have been contaminated in order to rule it out as the cause.We ask for feedback after checking the batch.
|
|
Event Description
|
It was reported that the patient developed sepsis after using syringe 10ml saline xs.The following information was provided by the initial reporter: we have a customer complaint about the following product: ref (b)(4) / lot 0154145 the patient has developed sepsis after connecting the nutritional solution.We ask that the batch of bd posiflush be examined to determine if it could have been contaminated in order to rule it out as the cause.We ask for feedback after checking the batch.
|
|
Manufacturer Narrative
|
H6: investigation summary: a device history record review was performed for provided lot number 0154145 and the review did not reveal any detected quality issues during the production process that could have directly contributed to this reported incident.During the production process and during final inspection of the product, the sterile barrier integrity is confirmed at several points, endotoxin bioburden tests are taken to ensure sterility, and environmental monitoring of the saline fill room is performed bi-weekly.The lab results for this process were reviewed and all of the testing in place ensured that the product was fit for its intended use and met the standard requirements for the product.There is no evidence that posiflush syringe was responsible for the patient¿s infection.
|
|
Search Alerts/Recalls
|